Business Context and Reporting Period
This Form 8-K, filed on June 19, 2017, reports on events occurring on June 16, 2017, involving Healthcare Trust, Inc. (the "Company"). The filing details the entry into a Material Definitive Agreement to acquire substantially all assets of American Realty Capital Healthcare Trust III, Inc. ("HT III"). Both entities are sponsored by AR Global Investments, LLC.
Key Financial Metrics and Transaction Terms
- Purchase Price: $120.0 million for 19 properties comprising substantially all of HT III's assets.
- Payment Structure: Payable on the Closing Date, subject to customary prorations and adjustments.
- Debt Assumption: The Company agreed to use commercially reasonable efforts to assume the "Philip Center Loan" with an outstanding principal balance of approximately $4.9 million as of June 16, 2017. If assumed, this amount is deducted from the cash purchase price.
- Escrow: $6.0 million of the Purchase Price will be deposited into an escrow account for 14 months post-closing.
- Termination Fee: HT III is required to pay the Company $3.6 million if the agreement is terminated due to a Change in Recommendation or material violation of exclusivity obligations.
- Expense Reimbursement: HT III agreed to reimburse the Company up to $850,000 for transaction-related expenses if the deal fails due to lack of stockholder approval.
Material Changes and Transaction Conditions
The transaction represents a significant expansion of the Company's portfolio through the acquisition of 19 healthcare properties. The consummation of the Asset Sale is subject to specific conditions, most notably the approval of the Asset Sale and HT III's plan of liquidation by holders of at least a majority of all votes entitled to be cast by HT III stockholders. The Company's board of directors, based on a unanimous recommendation from a special committee of independent directors, has approved the agreement.
Outlook, Risks, and Contingencies
Management Commentary: The board determined the transaction is advisable and in the best interests of the Company. The agreement includes standard representations and warranties surviving for 14 months post-closing.
Risks and Contingencies:
- Stockholder Approval: The deal is contingent on HT III obtaining stockholder approval; failure to do so may trigger expense reimbursements but not the termination fee.
- Debt Assumption Risk: If the Company fails to assume the Philip Center Loan or secure the release of HT III from the guaranty, the Seller Parties must repay the loan in full, and any early termination fees exceeding $200,000 will be subtracted from the Purchase Price.
- Indemnification: Indemnification liability is subject to a $500,000 threshold and capped at 10% of the Purchase Price. Seller Parties are liable for pre-closing taxes and stockholder litigation.
- Forward-Looking Statements: The filing warns that actual results may differ due to market volatility, regulatory actions, and the ability to complete the transaction.
Investor Verification Checklist
- Verify the status of HT III stockholder approval for the Asset Sale and Plan of Liquidation.
- Confirm whether the Philip Center Loan ($4.9 million) has been successfully assumed by the Company or repaid by Seller Parties.
- Review the full text of the Purchase Agreement (Exhibit 10.1) for specific representations, warranties, and indemnification exclusions.
- Monitor for any "Superior Proposals" that could trigger a Change in Recommendation by HT III's board.
- Assess the impact of the $6.0 million escrow holdback on immediate liquidity and cash flow upon closing.